DK0906294T3 - Benzoxazinon-dopamin D4-receptor-antagonister - Google Patents
Benzoxazinon-dopamin D4-receptor-antagonisterInfo
- Publication number
- DK0906294T3 DK0906294T3 DK97925651T DK97925651T DK0906294T3 DK 0906294 T3 DK0906294 T3 DK 0906294T3 DK 97925651 T DK97925651 T DK 97925651T DK 97925651 T DK97925651 T DK 97925651T DK 0906294 T3 DK0906294 T3 DK 0906294T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzoxazinone
- dopamine
- receptor antagonists
- antagonists
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1838396P | 1996-05-29 | 1996-05-29 | |
| US4020897P | 1997-03-06 | 1997-03-06 | |
| PCT/US1997/008524 WO1997045419A1 (en) | 1996-05-29 | 1997-05-20 | Benzoxazinone dopamine d4 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0906294T3 true DK0906294T3 (da) | 2003-05-05 |
Family
ID=26691052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97925651T DK0906294T3 (da) | 1996-05-29 | 1997-05-20 | Benzoxazinon-dopamin D4-receptor-antagonister |
Country Status (36)
| Country | Link |
|---|---|
| EP (1) | EP0906294B1 (cs) |
| JP (1) | JP2000511534A (cs) |
| KR (1) | KR20000016151A (cs) |
| CN (1) | CN1074764C (cs) |
| AR (1) | AR008372A1 (cs) |
| AT (1) | ATE231846T1 (cs) |
| AU (1) | AU731104B2 (cs) |
| BG (1) | BG64049B1 (cs) |
| BR (1) | BR9709630A (cs) |
| CA (1) | CA2253406A1 (cs) |
| CO (1) | CO4940505A1 (cs) |
| CZ (1) | CZ384698A3 (cs) |
| DE (1) | DE69718786T2 (cs) |
| DK (1) | DK0906294T3 (cs) |
| EA (1) | EA001486B1 (cs) |
| EE (1) | EE03686B1 (cs) |
| ES (1) | ES2191180T3 (cs) |
| GE (1) | GEP20012389B (cs) |
| HN (1) | HN1997000075A (cs) |
| HR (1) | HRP970301B1 (cs) |
| HU (1) | HUP9903758A3 (cs) |
| ID (1) | ID17266A (cs) |
| IL (1) | IL126895A (cs) |
| NO (1) | NO312296B1 (cs) |
| NZ (1) | NZ332737A (cs) |
| PA (1) | PA8431101A1 (cs) |
| PE (1) | PE69398A1 (cs) |
| PL (1) | PL330195A1 (cs) |
| PT (1) | PT906294E (cs) |
| RO (1) | RO120845B1 (cs) |
| SI (1) | SI0906294T1 (cs) |
| SK (1) | SK282703B6 (cs) |
| SV (1) | SV1997000047A (cs) |
| TW (1) | TW542833B (cs) |
| UY (1) | UY24569A1 (cs) |
| WO (1) | WO1997045419A1 (cs) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6177422B1 (en) | 1996-05-29 | 2001-01-23 | Warner-Lambert Company | Benzoxazinone dopamine D4 receptor antagonists |
| GB9801392D0 (en) * | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
| JP2002519346A (ja) * | 1998-06-30 | 2002-07-02 | ニューロゲン コーポレイション | １−（ベンゾチアゾール−２−イル）−４−（１−フェニルメチル）ピペラジン：ドーパミン受容体サブタイプ特異リガンド |
| US6177566B1 (en) | 1998-06-30 | 2001-01-23 | Neurogen Corporation | 6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands |
| US6291463B1 (en) | 1998-06-30 | 2001-09-18 | Neurogen Corporation | 1-(Benzothiazol-2-yl)-4-(1-phenylmethyl) piperazines: dopamine receptor subtype specific ligands |
| EP1091949A2 (en) * | 1998-06-30 | 2001-04-18 | Neurogen Corporation | 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| DE19844291A1 (de) * | 1998-09-18 | 2000-03-23 | Schering Ag | Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln |
| GB9912411D0 (en) * | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
| CZ20031163A3 (cs) * | 2000-10-26 | 2004-04-14 | Smithkline Beecham P. L. C. | Deriváty benzoxazinonu, způsob jejich přípravy, jejich použití a farmaceutický prostředek, který je obsahuje |
| GB0203804D0 (en) | 2002-02-18 | 2002-04-03 | Glaxo Group Ltd | Compounds |
| GB0209244D0 (en) * | 2002-04-23 | 2002-06-05 | Glaxo Group Ltd | Compounds |
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| ES2232292B1 (es) * | 2003-07-30 | 2006-11-01 | Laboratorios Del Dr. Esteve, S.A. | Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos. |
| CN100455573C (zh) * | 2005-11-11 | 2009-01-28 | 华东理工大学 | 一种制备1,4-苯并噁唑嗪-3-酮化合物的微波合成方法 |
| KR200482995Y1 (ko) | 2015-08-19 | 2017-03-23 | 이현진 | 물 공급부를 구비하는 얼음 트레이 |
| JP2024514338A (ja) * | 2021-04-23 | 2024-04-01 | 上▲海▼翰森生物医▲薬▼科技有限公司 | 複素環式誘導体阻害剤及びその調製方法及びその用途 |
| JP2025510646A (ja) | 2022-03-14 | 2025-04-15 | スラップ ファーマシューティカルズ エルエルシー | 多環式化合物 |
| CN119487027A (zh) * | 2022-04-28 | 2025-02-18 | 宁波新湾科技发展有限公司 | 作为parp1抑制剂的化合物 |
| CN117903159A (zh) * | 2022-12-30 | 2024-04-19 | 成都硕德药业有限公司 | 一种内酰胺类衍生物、其制备方法及用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4613598A (en) * | 1984-03-13 | 1986-09-23 | Mitsubishi Chemical Industries Limited | Piperazine derivatives and their acid addition salts |
| EP0233728A1 (en) * | 1986-02-11 | 1987-08-26 | Takeda Chemical Industries, Ltd. | 1,4-Benzoxazine derivatives their production and use |
| ATE171162T1 (de) * | 1992-08-06 | 1998-10-15 | Smithkline Beecham Plc | 5-(2-oxyphenyl)-pyrrol-derivate als dopamin-d3- rezeptor-antagonisten |
-
1997
- 1997-05-20 EE EE9800417A patent/EE03686B1/xx not_active IP Right Cessation
- 1997-05-20 DK DK97925651T patent/DK0906294T3/da active
- 1997-05-20 AT AT97925651T patent/ATE231846T1/de not_active IP Right Cessation
- 1997-05-20 BR BR9709630A patent/BR9709630A/pt not_active Application Discontinuation
- 1997-05-20 EP EP97925651A patent/EP0906294B1/en not_active Expired - Lifetime
- 1997-05-20 HU HU9903758A patent/HUP9903758A3/hu unknown
- 1997-05-20 CZ CZ983846A patent/CZ384698A3/cs unknown
- 1997-05-20 AU AU30727/97A patent/AU731104B2/en not_active Ceased
- 1997-05-20 KR KR1019980709719A patent/KR20000016151A/ko not_active Ceased
- 1997-05-20 IL IL12689597A patent/IL126895A/en not_active IP Right Cessation
- 1997-05-20 CN CN97195015A patent/CN1074764C/zh not_active Expired - Fee Related
- 1997-05-20 DE DE69718786T patent/DE69718786T2/de not_active Expired - Fee Related
- 1997-05-20 PT PT97925651T patent/PT906294E/pt unknown
- 1997-05-20 GE GEAP19974623A patent/GEP20012389B/en unknown
- 1997-05-20 EA EA199800987A patent/EA001486B1/ru not_active IP Right Cessation
- 1997-05-20 PL PL97330195A patent/PL330195A1/xx unknown
- 1997-05-20 ES ES97925651T patent/ES2191180T3/es not_active Expired - Lifetime
- 1997-05-20 JP JP09542647A patent/JP2000511534A/ja not_active Ceased
- 1997-05-20 SK SK1627-98A patent/SK282703B6/sk unknown
- 1997-05-20 WO PCT/US1997/008524 patent/WO1997045419A1/en not_active Ceased
- 1997-05-20 CA CA002253406A patent/CA2253406A1/en not_active Abandoned
- 1997-05-20 SI SI9730482T patent/SI0906294T1/xx unknown
- 1997-05-20 NZ NZ332737A patent/NZ332737A/en unknown
- 1997-05-20 RO RO98-01622A patent/RO120845B1/ro unknown
- 1997-05-22 HN HN1997000075A patent/HN1997000075A/es unknown
- 1997-05-27 AR ARP970102249A patent/AR008372A1/es unknown
- 1997-05-28 TW TW086107221A patent/TW542833B/zh active
- 1997-05-28 SV SV1997000047A patent/SV1997000047A/es not_active Application Discontinuation
- 1997-05-28 CO CO97029474A patent/CO4940505A1/es unknown
- 1997-05-28 ID IDP971778A patent/ID17266A/id unknown
- 1997-05-28 PA PA19978431101A patent/PA8431101A1/es unknown
- 1997-05-28 PE PE1997000432A patent/PE69398A1/es not_active Application Discontinuation
- 1997-05-28 UY UY24569A patent/UY24569A1/es not_active Application Discontinuation
- 1997-05-29 HR HR970301A patent/HRP970301B1/xx not_active IP Right Cessation
-
1998
- 1998-11-26 BG BG102959A patent/BG64049B1/bg unknown
- 1998-11-27 NO NO19985531A patent/NO312296B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| NO986110D0 (no) | IL-8 reseptor-antagonister | |
| NO986109D0 (no) | IL-8 reseptor-antagonister | |
| DE69812096D1 (de) | Neuropeptid y rezeptorantagonisten | |
| NO972016D0 (no) | Indolyl-Y-reseptorantagonister | |
| FI955223L (fi) | Adheesioreseptoriantagonisteja | |
| EP0986385A4 (en) | GONADORELIN ANTAGONISTS | |
| ATE233260T1 (de) | Muscarin-antagonisten | |
| DE69833073D1 (de) | CCR-3-Rezeptor-Antagonisten | |
| NO993586D0 (no) | K-8 reseptor antagonister | |
| EP0885205A4 (en) | Fibrinogen Receptor Antagonists | |
| NO990668D0 (no) | IL-8 reseptor antagonister | |
| EP0866705A4 (en) | FIBRINOGENIC RECEPTOR ANTAGONISTS | |
| ID23168A (id) | Reseptor anatagonis vitronektin | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| DK0906294T3 (da) | Benzoxazinon-dopamin D4-receptor-antagonister | |
| NO950606D0 (no) | Adhesjonsreseptor-antagonister | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| BR9707733A (pt) | Antagonistas de receptores muscarinicos oxa-e-tia-diazol | |
| EP0929218A4 (en) | P2Y RECEPTOR ANTAGONISTS | |
| TR199501389A2 (tr) | Adesyon reseptörü antagonistleri (karsitlari). | |
| BR9507220A (pt) | Antagonistas de receptores de endotelina | |
| DZ2322A1 (fr) | Antagonistes de récepteurs de vitronectine. | |
| DE69735811D1 (de) | Piperazinoderivate als neurokinin-antagonisten | |
| EP0957908A4 (en) | FIBRINOGEN RECEPTOR ANTAGONISTS |